Homburger | View firm profile
On May 27, 2025, a consortium led by EQT, consisting of Sunshine SwissCo GmbH, the Abu Dhabi Investment Authority (ADIA) and Auba Investment Pte. Ltd. (all acting as the Sellers), announced the launch of an accelerated bookbuilding process to professional investors in Switzerland and to qualified investors outside Switzerland, which led to the successful placement of 19,031,811 shares in Galderma Group AG (Galderma) at a price of CHF 97.75 per share (the Placement), raising a total of ca. CHF 1,860 m in total.
Galderma participated in the Placement by agreeing to repurchase 2,378,976 shares for a total consideration of ca. CHF 233 m, at the same price per share determined by the bookbuilding process.
The Sellers will remain shareholders of 40.2% of the share capital of Galderma. EQT’s representation on the board of directors of Galderma remains unchanged as a result of the Placement. Such Placement will broaden Galderma’s shareholder base and free float. In connection therewith, the Sellers have agreed to a 90-day lock-up period, subject to certain customary exceptions, with respect to their remaining holding in Galderma.
The Placement is expected to be settled on June 2, 2025. Following the Placement, no changes to the Galderma board of directors and its governance are envisioned.
Homburger acted as transaction counsel to EQT.
The Homburger team was led by Frank Gerhard (Corporate / M&A, Capital Markets) and included Margrit Marti, Estelle Piccard, Héloïse de Jamblinne and Lucas Forrer (all Corporate / M&A, Capital Markets), Micha Fankhauser (Financial Market Regulation) as well as Stefan Oesterhelt (Tax).
Contact
Nanding Susso / Marketing / [email protected]